Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
29MAY

Spinout deals fall 33% as seed dries up

2 min read
14:17UTC

University spinout equity deals fell 33% by count and 51% by value in 2025, extending a pipeline already skewed to sub-GBP500,000 rounds.

← Back to Orbital's $50m has no UK leadJump to analysis ↓
TechnologyDeveloping
Key takeaway

University spinout funding is drying up, thinning the pipeline of scale-ups Britain will have in 2027.

University spinout equity deals fell 33% by count and 51% by value in 2025, the sharpest contraction in the commercialisation pipeline this cycle, the British Business Bank tracker showed 1. It extends a figure already on the record: 36.7% of 2025 spinout rounds closed below GBP500,000.

Universities carve spinouts out of their research to commercialise it. Fewer seed-stage spinouts now means a shallower Series A pipeline in 2027, since the funding stages feed one another; capital that might have scaled university science will chase other sectors instead.

The retail money that once seeded these companies has thinned. His Majesty's Revenue and Customs (HMRC) counted 33,220 investors using the Enterprise Investment Scheme (EIS), a tax relief for angels backing young firms, down 7% , before April's cut to Venture Capital Trust (VCT) relief compounded the fall. Private managers are rebuilding the tier by hand: Seedcamp closed a $320m fund , the Bank cornerstoned Longwall Ventures for sub-GBP2m cheques , and Lansdowne Partners anchored a university-IP fund . Each is selective, none is an open programme, so the recovery reaches some founders and not others.

Deep Analysis

In plain English

University spinouts are companies created to commercialise research done inside a university, such as a new drug or piece of hardware. In 2025 the number of spinout equity deals fell 33% and the total money raised fell 51%, with more than a third of all spinout rounds closing below £500,000, a very small amount for a company trying to build a product from a lab discovery. Much of the money that used to back these small, risky early rounds came from individual investors using tax reliefs called EIS and VCT. Government figures already showed 7% fewer people claiming that relief before ministers cut it further in April 2026, drying up one of the few funding taps spinouts could rely on.

Deep Analysis
Root Causes

Two separate mechanisms compound rather than one single cause. HMRC data already showed a 7% fall in EIS-claiming investors before this April's Venture Capital Trust relief cut took effect , meaning the retail angel base was thinning independently of the policy change.

The April 2026 VCT relief cut then removed a second, larger pool of retail capital that specifically fills reserve rounds below £2m, the exact size band where 36.7% of 2025 spinout rounds closed. Losing both pools within eighteen months hit the smallest deals hardest, because they have no alternative source of patient, tax-advantaged capital at that size.

What could happen next?
  • Consequence

    Fewer sub-£2m spinout rounds closing means fewer early-stage discoveries reach commercialisation at all, regardless of their eventual quality.

Sources:British Business Bank
Mentions:British Business Bank →HMRC →Seedcamp →Longwall Ventures →Lansdowne Partners →Venture Capital Trusts →Enterprise Investment Scheme →Germany →Fudan University →
First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

British Business Bank· 4 Jul 2026
Read original →
Causes and effects
Caused by
Angel base shrank 7% before the cut
The 7% fall in EIS angel investors is a direct driver of the shrinking spinout equity tier.
Occurred 1 May 2026
Read story →
Midlands fund writes its first cheques
Midlands Mindforge's university-spinout fund is one of the private vehicles rebuilding the sub-GBP2m spinout tier the tracker shows contracting.
Occurred 10 Jun 2026
Read story →
Seedcamp closes its record $320m fund
Seedcamp's $320m fund close is part of the private-manager rebuild of the seed and spinout tier.
Occurred 22 Jun 2026
Read story →
State £50m backs the tier funds skip
The British Business Bank's Longwall Ventures cornerstone backstops the sub-GBP2m tier the tracker shows contracting.
Occurred 27 May 2026
Read story →
Lansdowne hits €128.9m on BBB-anchored fund
Lansdowne Partners' university-IP fund is part of the private capital rebuilding the spinout tier.
Occurred 14 May 2026
Read story →
UKRI confirms 58% cut to STFC labs
Connects to the tracker's 33% fall in spinout deal count, the same base STFC cuts thin further.
Occurred 9 Jul 2026
Read story →
This Event
Spinout deals fall 33% as seed dries up
A thinner spinout tier now feeds directly into a shallower Series A pipeline in 2027, independent of how much growth capital exists.
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.